PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
65.60%
Positive growth while CRON.TO shows revenue decline. John Neff would investigate competitive advantages.
52.09%
Cost growth above 1.5x CRON.TO's 14.29%. Michael Burry would check for structural cost disadvantages.
109.55%
Positive growth while CRON.TO shows decline. John Neff would investigate competitive advantages.
26.54%
Margin expansion while CRON.TO shows decline. John Neff would investigate competitive advantages.
14.17%
R&D growth less than half of CRON.TO's 134.00%. David Dodd would verify if efficiency advantage is sustainable.
-27.70%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
2.96%
Marketing expense growth less than half of CRON.TO's 191.21%. David Dodd would verify if efficiency advantage is sustainable.
35090.53%
Other expenses growth while CRON.TO reduces costs. John Neff would investigate differences.
-19.91%
Operating expenses reduction while CRON.TO shows 45.19% growth. Joel Greenblatt would examine advantage.
19.11%
Total costs growth 50-75% of CRON.TO's 30.37%. Bruce Berkowitz would examine efficiency.
546.34%
Interest expense growth less than half of CRON.TO's 1320.71%. David Dodd would verify sustainability.
43.28%
D&A growth while CRON.TO reduces D&A. John Neff would investigate differences.
126.61%
EBITDA growth while CRON.TO declines. John Neff would investigate advantages.
263.02%
EBITDA margin growth exceeding 1.5x CRON.TO's 65.42%. David Dodd would verify competitive advantages.
77.73%
Operating income growth while CRON.TO declines. John Neff would investigate advantages.
86.55%
Operating margin growth while CRON.TO declines. John Neff would investigate advantages.
1948.33%
Other expenses growth while CRON.TO reduces costs. John Neff would investigate differences.
113.92%
Pre-tax income growth while CRON.TO declines. John Neff would investigate advantages.
108.40%
Pre-tax margin growth while CRON.TO declines. John Neff would investigate advantages.
103.74%
Similar tax expense growth to CRON.TO's 98.06%. Walter Schloss would investigate patterns.
115.00%
Net income growth while CRON.TO declines. John Neff would investigate advantages.
109.06%
Net margin growth while CRON.TO declines. John Neff would investigate advantages.
115.13%
EPS growth while CRON.TO declines. John Neff would investigate advantages.
114.87%
Diluted EPS growth while CRON.TO declines. John Neff would investigate advantages.
0.41%
Share count reduction exceeding 1.5x CRON.TO's 2.07%. David Dodd would verify capital allocation.
1.04%
Diluted share reduction below 50% of CRON.TO's 1.64%. Michael Burry would check for concerns.